Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging small molecular inhibitors as targeted therapies for high-risk acute myeloid leukemias.

Expert review of hematology - 1 Jan 2000

Sahasrabudhe Kieran D, Albrethsen Mary, Mims Alice S

Abstract excerpt

INTRODUCTION: Acute myeloid leukemia (AML) is an aggressive disease which has traditionally been treated with intensive chemotherapy. Survival in patients with high-risk cytogenetic and molecular subsets has been poor with this approach due to suboptimal responses seen with intensive chemotherapy and due to many patients with higher risk disease being older and unable to tolerate intensive therapies. In recent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Source

Identifiers

PMID: 37405412
DOI: 10.1080/17474086.2023.2233701

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging small molecular inhibitors as targeted therapies for high-risk acute myeloid leukemias.PMID 37405412Read ↗

Recent advances in targeted therapies in acute myeloid leukemia.Semantic proximity Read ↗

Update on Small Molecule Targeted Therapies for Acute Myeloid Leukemia.Semantic proximity Read ↗

An Overview of Targeted Therapies in Acute Myeloid LeukemiaSemantic proximity Read ↗

Moving toward individualized target-based therapies in acute myeloid leukemia.Semantic proximity Read ↗

Molecularly targeted therapy in acute myeloid leukemia.Semantic proximity Read ↗

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid LeukemiaSemantic proximity Read ↗

Emerging therapies for acute myeloid leukemia: translating biology into the clinic.Semantic proximity Read ↗

Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting ChallengesSemantic proximity Read ↗

Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question.Semantic proximity Read ↗

Novel Therapeutics in Acute Myeloid Leukemia.Semantic proximity Read ↗

Acute myeloid leukemia: advancing clinical trials and promising therapeutics.Semantic proximity Read ↗

Advances in the pharmacological management of acute myeloid leukemia in adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.